Cleared Traditional

K193159 - NeuroAmp II

K193159 is the FDA 510(k) clearance for NeuroAmp II by Corscience GmbH & Co. KG. It is a Class 2 Neurology device (product code GWQ) cleared through the Traditional 510(k) pathway after a 411-day FDA review.

K193159 · Corscience GmbH & Co. KG · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
411d
Days
Class 2
Risk

K193159 is an FDA 510(k) clearance for the NeuroAmp II, NeuroAmp II.5s. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Corscience GmbH & Co. KG (Erlangen, DE). The FDA issued a Cleared decision on December 30, 2020 after a review of 411 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Corscience GmbH & Co. KG devices

Submission Details

510(k) Number K193159 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 2019
Decision Date December 30, 2020
Days to Decision 411 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
263d slower than avg
Panel avg: 148d · This submission: 411d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 87
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K193159.
iSyncWave
K220056 · iMediSync, Inc. · Aug 2022
Seer Home
K212788 · Seer Medical Pty, Ltd. · Jun 2022
WAVi SCAN EEG System and Accessories
K213900 · Wavi Co. · May 2022
Neuronaute
K202334 · Bioserenity Sas · Dec 2020
Cadwell Apollo System
K201819 · Cadwell Industries, Inc. · Sep 2020
Maxxi Position Sensor
K191492 · Neurovirtual USA, Inc. · Apr 2020